Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 314 publications
Same tumor, different lungs: How chronic obstructive pulmonary disease and interstitial lung disease reshape lung cancer risk and treatment.
Journal: Journal of translational internal medicine
Published: August 27, 2026
Correction: Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.
Journal: Targeted oncology
Published: June 30, 2026
Diversity of Iodinated Water Disinfection Byproducts and Their Formation Dynamics Discovered Using Exposome-Scale Nontargeted Analysis and Machine Learning.
Journal: Environmental science & technology
Published: June 26, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: June 18, 2026
Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2026
Rare Fusions, Real Targets: Ultraprecision Oncology in Lung Cancer.
Journal: Cancer discovery
Published: June 09, 2026
Incorporating CRISPR Techniques with Electrochemical Sensors: From Signal-Off to Signal-On Assays.
Journal: ACS sensors
Published: May 09, 2026
CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.
Journal: JCO precision oncology
Published: April 23, 2026
Fish Remain High in Selenium Long after Mountaintop Coal Mines Close.
Journal: Environmental science & technology
Published: April 14, 2026
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. Reply.
Journal: The New England journal of medicine
Published: March 26, 2026
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 20, 2026
Last Updated: 09/26/2026